医药分开的内涵与实现途径探讨  

Separating drug sales from medical services: Connotations and approaches

作　　者：王贤吉[1,2] 付晨[3] 金春林 晏波[3] 彭玉梅[3] 陈小丽[3] 陈卓蕾[3] 

机构地区：[1]上海市卫生发展研究中心,上海200040 [2]复旦大学公共卫生学院,上海200032 [3]上海市卫生局,上海200040

出　　处：《中国卫生政策研究》2013年第1期36-39,共4页Chinese Journal of Health Policy

基　　金：上海市卫生系统优秀青年人才培养计划项目(XYQ2011052)

摘　　要：本文围绕什么是医药分开和如何实现医药分开进行探讨,提出医药分开的核心是切断公立医院、医生与药品之间的利益纽带;取消药品加成不等于医药分开,但它是医药分开的必要措施,且现阶段取消药品加成对于打破我国公立医院改革的僵局而言有重要意义;"医"和"药"的真正分开不仅要在补偿机制上下功夫,还需要同步推进药品价格形成机制、公立医院监管考核机制和运行机制等方面的综合改革。In this paper, we focus on what it means to separate drug sales from medical services and how to re- alize this separation. We suggest that separating drug sales from medical services involves cutting the interest ties a- mong public hospitals, doctors, and drug manufacturers and suppliers. Scrapping the drug markup in public hospitals does not in itself separate medical services from drug sales ; however, it is an essential first step in public hospital re- form in China. Completing this separation relies not only on reforming compensation mechanisms, but also reforming supervision and assessment, pricing, and operational mechanisms.

关 键 词：公立医院 医药分开 药品加成 

分 类 号：R951[医药卫生—药学]